us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $110.39

    as of February 20, 2026
  • YTD RETURNS
    7.05%

    as of February 20, 2026
  • Total Net Assets
    $1.33B

    as of February 20, 2026
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Tracks the largest most liquid pharmaceutical companies
  • Industry Leaders: Favors established industry leaders with meaningful scale
  • Global Scope: Provides exposure to U.S. and international equities for global industry representation  

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 3.54 15.75 3.54 22.46 13.13 11.48 7.90 10.21
PPH (Share Price) 3.53 15.77 3.53 22.58 13.16 11.47 7.94 10.28
MVPPHTR (Index) 3.52 15.75 3.52 22.13 12.69 11.10 7.67 10.02
Performance Differential (NAV - Index) 0.02 -- 0.02 0.33 0.44 0.38 0.23 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.86 14.97 21.92 21.92 12.11 11.34 6.74 10.00
PPH (Share Price) 0.95 15.00 22.03 22.03 12.14 11.34 6.73 10.08
MVPPHTR (Index) 0.89 15.01 21.58 21.58 11.64 10.88 6.49 9.81
Performance Differential (NAV - Index) -0.03 -0.04 0.34 0.34 0.47 0.46 0.25 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 02/20/2026

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $110.39
$110.38 		440,731
199,177 		$-0.58 / -0.52%
$-0.57 / -0.51% 		+7.05%
+6.99% 		$-0.01
-0.01% 		0.04%

Fees

Holdings

Daily Holdings (%) as of 02/20/2026

Download XLS Get holdings
Total Holdings: 26
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY US
 Eli Lilly & Co 18.30
BBG000BNBDC2
239,861
 Stock 242,144,477 --
NVS US
 Novartis Ag 11.10
BBG000LYF3S8
903,137
 Stock 146,913,296 --
MRK US
 Merck & Co Inc 9.69
BBG000BPD168
1,048,367
 Stock 128,173,349 --
NVO US
 Novo Nordisk A/S 5.63
BBG000BQBKR3
1,571,640
 Stock 74,527,169 --
GSK US
 Gsk Plc 4.98
BBG000BLB481
1,107,719
 Stock 65,931,435 --
BMY US
 Bristol-Myers Squibb Co 4.80
BBG000DQLV23
1,047,147
 Stock 63,519,937 --
JNJ US
 Johnson & Johnson 4.76
BBG000BMHYD1
259,630
 Stock 62,957,679 --
MCK US
 Mckesson Corp 4.72
BBG000DYGNW7
65,953
 Stock 62,489,148 --
PFE US
 Pfizer Inc 4.65
BBG000BR2B91
2,311,195
 Stock 61,593,347 --
AZN US
 Astrazeneca Plc 4.50
BBG000D3MHB4
291,858
 Stock 59,597,404 --
ABBV US
 Abbvie Inc 4.05
BBG0025Y4RY4
238,134
 Stock 53,534,905 --
COR US
 Cencora Inc 3.97
BBG000MDCQC2
145,538
 Stock 52,550,861 --
SNY US
 Sanofi Sa/France 3.93
BBG000BBD5N1
1,111,159
 Stock 51,957,795 --
ZTS US
 Zoetis Inc 3.34
BBG0039320N9
343,153
 Stock 44,191,243 --
HLN US
 Haleon Plc 3.13
BBG018GZNCH6
3,679,042
 Stock 41,462,803 --
TAK US
 Takeda Pharmaceutical Co Ltd 2.90
BBG000LF8708
2,054,680
 Stock 38,340,329 --
TEVA US
 Teva Pharmaceutical Industries Ltd 2.68
BBG000C0CD58
1,034,586
 Stock 35,403,533 --
VTRS US
 Viatris Inc 0.89
BBG00Y4RQNH4
743,735
 Stock 11,840,261 --
JAZZ US
 Jazz Pharmaceuticals Plc 0.60
BBG000G9CGL0
46,156
 Stock 7,947,602 --
AXSM US
 Axsome Therapeutics Inc 0.47
BBG00B6G7GL7
33,516
 Stock 6,157,560 --
ELAN US
 Elanco Animal Health Inc 0.45
BBG00LJYS1P8
235,910
 Stock 5,893,032 --
CORT US
 Corcept Therapeutics Inc 0.16
BBG000BKJG33
60,932
 Stock 2,121,652 --
OGN US
 Organon & Co 0.11
BBG00ZQRGW24
187,628
 Stock 1,516,034 --
BHC US
 Bausch Health Cos Inc 0.09
BBG000DLFM21
197,212
 Stock 1,208,910 --
PRGO US
 Perrigo Co Plc 0.09
BBG000CNFQW6
75,800
 Stock 1,134,726 --
-USD CASH-
 -0.00
--
-3,192
 Cash Bal -3,192 --
--
Other/Cash 0.02
--
0
 Cash 288,158 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 01/31/2026

  • Sector

    % of Net Assets

  • Health Care

    99.80

  • Other/Cash

    0.20

Country Weightings (%) as at 01/31/2026

  • Country

    % of Net Assets

  • United States

    60.80

  • United Kingdom

    11.69

  • Switzerland

    10.46

  • Denmark

    7.28

  • France

    4.07

  • Japan

    2.76

  • Israel

    2.75

  • Other/Cash

    0.20

Distributions

Yields  as of  02/20/2026

Distribution Frequency

Quarterly

30-Day SEC Yield

1.81%

Distribution Yield

1.13%

12 Month Yield

1.66%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 1.81% on 02/20/26. Distributions may vary from time to time.

Team

Literature

PPH